Developing extravasation protocols and monitoring outcomes

Journal of Intravenous Nursing

Volumn 21, Issue 4, 1998, Pages 232-239

  Camp Sorrell, Dawn ^a  

^a UNIVERSITY OF ALABAMA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; DISTRESS SYNDROME; EXTRAVASATION; HUMAN; PATIENT MONITORING; REVIEW; TISSUE NECROSIS;

ADULT; ANTIDOTES; ANTINEOPLASTIC AGENTS; CLINICAL PROTOCOLS; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; NURSING RECORDS; ONCOLOGIC NURSING; PRACTICE GUIDELINES; RISK FACTORS;

EID: 0031821759     PISSN: 08965846     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. McGuffin B, Mariani M. Clinical nursing standards: towards a synthesis. Journal of Nursing Qualily Assurance 1990;4(3):35-45.
2. American Nurses Association. Task force on nursing practice standards and guidelines: working paper. Journal of Nursing Qualily Assurance 1991;5(3):1-17.
3. Miaskowski C, Rostad M. Implementing the ANA/ONS standards of oncology nursing practice. Journal of Nursing Qualily Assurance 1990;4(3):15-23.
4. Bertelli G. Prevention and management of extravasation of cytotoxic drugs. Drug Safety 1994;12(4):245-55.
5. Scuderi N, Onesti MG. Antitumor agents: extravasation, management and surgical treatment. Ann Plast Surg 1994;32:39-44.
6. Dorr RT. Antidotes to vesicant chemotherapy. Blood Rev 1990; 4:41-60.
7. Brothers TE, VonMoll LK, Niederhuber JE, et al. Experience with subcutaneous infusion ports in 300 patients. Surg Gynecol Obstet 1988;166:295-301.
8. Powel LL. Cancer chemotherapy guidelines and recommendations for practice. Pittsburgh: Oncology Nursing Society Press, 1996; 15-6.
9. Andersson AP, Dahlstrom KK. Clinical results after doxorubicin extravasation treated with excision guided by fluorescence microscopy. Eur J Cancer 1993;29A:1712-4.
10. Chrystal C. Administering continuous vesicant chemotherapy in the ambulatory setting. Journal of Intravenous Nursing 1997;20:78-88.
11. Poorter RL, Lauw FN, Bemelman WA, et al. Complications of an implantable venous access device (Port-a-Cath®) during intermittent continuous infusion of chemotherapy. Eur J Cancer 1996;32A: 2262-6.
12. Herrington JD, Figureoa JA. Severe necrosis due to paclitaxel extravasation. Pharmacotherapy 1997;17:163-5.
13. Ingle RJ. Rare complications of vascular access devices. Semin Oncol Nurs 1995;11:184-93.
14. Rodier JM, Malbec L, Lauraine EP, et al. Mediastinal infusion of epirubicin and 5 FU. A complication of totally implanted central venous system. Report of a case. Journal of Cancer Research and Clinical Oncology 1996;122:566-7.
15. Mayo DJ, Pearson DC. Chemotherapy extravasation: a consequence of fibrin sheath formation around venous access devices. Oncology Nursing Forum 1995;22:675-80.
16. Whitman E. Complications associated with the use of central venous devices. Curr Probl Surg 1996;33:311-78.
17. Bertelli G, Dini D, Forno G, et al. Hyaluronidase as an antidote to extravasation of vinca alkaloids: clinical results. Journal of Cancer Research and Clinical Oncology 1994;120:505-6.
18. Dorr RT, Alberts DS, Chen HSG. The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse. Cancer Chemother Pharmocol 1980;5:17-20.
19. Kappel B, Hindeburg, A, Taub RN. Treatment of anthracycline extravasation - a warning against the use of sodium bicarbonate. J Clin Oncol 1987;5:825-6.
20. Lebredo L, Barrie R, Woltering EA. DMSO protects against adriamycin-induced tissue necrosis. J Surg Res 1992;53:62-5.
21. Rospond RM, Engel LM. Dimethyl sulfoxide for treating anthracycline extravasation. Clin Pharm 1993;12:560-1.
22. Bertelli G, Gozzo A, Forno GB, et al. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 1995;13: 2851-5.
23. Olver IN, Aisner J, Hament A, et al. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. J Clin Oncol 1988;6:1732-5.
24. St. Germain B, Houlihan N, D'Amato S. Dimethylsulfoxide therapy in the treatment of vesicant extravasation. Journal of Intravenous Nursing 1994;17:261-6.
25. Monstrey SJ, Mullick P, Narayanan K, et al. Hyperbaric oxygen therapy and free radical production: an experimental study in an doxorubicin (Adriamycin) extravasation injuries. Ann Plast Surg 1997; 38:163-8.
26. Boyle DM, Engelking C. Vesicant extravasation: myths and realities. Oncology Nursing Forum 1995;22:57-67.
27. Rudolph R, Larson RL. Etiology and treatment of chemotherapeutic agent extravasation injuries: a review. J Clin Oncol 1987;5: 1116-26.